10:17 AM EDT, 08/06/2024 (MT Newswires) -- Enfusion ( ENFN ) stock was down 0.6% in recent Tuesday trading even after the company posted higher Q2 results.

The company reported Q2 net income of $0.02 per diluted share, up from $0.01 a year earlier.

Analysts polled by Capital IQ expected $0.02.

Revenue for the quarter ended June 30 was $49.5 million, up from $42.7 million a year earlier.

Analysts surveyed by Capital IQ expected revenue of $50 million.

The investment management software company said it continues to expect 2024 revenue of between $200 million and $210 million. Analysts polled by Capital IQ expect $205.6 million.

Price: 8.60, Change: -0.05, Percent Change: -0.64